Public-registry site landscape for NCT05802329, a Center Involved Diabetic Macular Edema study sponsored by Ocugen. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05802329 (registry record) |
| Sponsor | Ocugen |
| Condition(s) | Center Involved Diabetic Macular Edema; Diabetic Macular Edema |
| Phase | PHASE1 |
| Listed sites | 5 |
| Site countries | United States |
At Advanced Research LLC — one of the facilities listed on this trial — 1 other study is actively recruiting Center Involved Diabetic Macular Edema patients at the same facility (public registry, as of August 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT05802329 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →